Since the entrance of Tunisia to the World Trade Organisation (WTO) in 1995, the Tunisian pharmaceutical industry has recorded considerable changes. Notably, with the extension of patentability to pharmaceuticals, the sector is now at a dynamic stage of transformation, translated by a notable development of the industry of generics. The purpose of this paper is to analyze the mutations that have marked the Tunisian pharmaceutical industry over the last decade and study its potential of developing future innovation. In this purpose, the paper is divided into two main parts. In the first one, we are going to present the legal and economic changes in the Tunisian pharmaceutical sector and highlight the emphasis of the government on the production of generics. In the second part, the paper aims at studying the perspectives for innovation in Tunisia through the study of the innovation capabilities in the Tunisian pharmaceutical sector. The results show that in spite of some strengths of the Tunisian economy, the perspectives for pharmaceutical innovation remain handicapped by several financial and structural deficiencies of the national and pharmaceutical innovation systems. Depuis l’adhésion de la Tunisie à l’Organisation Mondiale du Commerce (OMC) en 1995, le secteur pharmaceutique tunisien enregistre des changements considérables. Il se situe aujourd’hui à un stade dynamique de transformations, traduites particulièrement par le développement notable de l’industrie des génériques. L’objectif de cet article consiste donc à analyser les mutations ayant marqué le secteur pharmaceutique tunisien durant la dernière décennie et d’étudier son potentiel d’innovation. Dans cette perspective, l’article s’articule autour de deux grandes parties. Dans la première, nous allons exposer les changements réglementaires et économiques du secteur pharmaceutique tunisien et mettre l’accent surtout sur l’incitation du gouvernement pour la production des génériques. Dans la seconde partie, nous nous proposons d’étudier les perspectives d’innovation en Tunisie à travers l’étude des capacités d’innovation locales dans le secteur pharmaceutique. Les résultats montrent qu’en dépit de certaines forces qui caractérisent l’économie tunisienne par comparaison à d’autres Pays En Développement (PED) similaires, les perspectives d’innovation pharmaceutique demeurent handicapées par nombreuses défaillances financières et structurelles liées aux systèmes national et pharmaceutique d’innovation.
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
Publisher Info
Paper provided by Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation in its series Working Papers with number
190.
Length: 25 Date of creation: Jul 2008 Date of revision: Publication status: Published in Cahiers du Lab.RII, July 2008 Handle: RePEc:rii:riidoc:190
Contact details of provider: Postal: Maison de la recherche en sciences de l'homme, 21 quai de la Citadelle, 59140 Dunkerque Phone: (33) 3 28 23 71 35 Fax: (33) 3 28 23 71 43 or (33) 3 28 23 71 10 Email: Web page: http://riifr.univ-littoral.fr/ More information through EDIRC
For technical questions regarding this item, or to correct its listing, contact: (Philippe Chagnon).
References listed on IDEAS Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
Did you know? You can import bibliographic info in various formats into you bibliographic tool, or just into your word processor. See under "publisher info" on each abstract page.